These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 22095801
1. White House addresses drug shortages. Traynor K. Am J Health Syst Pharm; 2011 Dec 01; 68(23):2204, 2206. PubMed ID: 22095801 [No Abstract] [Full Text] [Related]
2. Drug shortages--Congress listens, FDA acts. Thompson CA. Am J Health Syst Pharm; 2012 Jan 15; 69(2):90-1. PubMed ID: 22215347 [No Abstract] [Full Text] [Related]
3. Laws fail to slow gray market. Concerns raised over secondary drug distributors. Lee J. Mod Healthc; 2011 Oct 03; 41(40):14. PubMed ID: 22049854 [No Abstract] [Full Text] [Related]
4. PDUFA V goes back to basics. Mullard A. Nat Rev Drug Discov; 2012 Aug 03; 11(8):586-8. PubMed ID: 22850772 [No Abstract] [Full Text] [Related]
5. New FDA law will help preserve production of "life-saving" drugs. Thompson CA. Am J Health Syst Pharm; 2012 Aug 15; 69(16):1352, 1354. PubMed ID: 22855095 [No Abstract] [Full Text] [Related]
6. Access to safety data--stockholders versus prescribers. Pfeffer MA, Bowler MB. N Engl J Med; 2011 Jul 07; 365(1):1-3. PubMed ID: 21714642 [No Abstract] [Full Text] [Related]
7. Supply Shortages: A Silver Lining. Gupta A, Mang N, Wei W, Ortwine J, Bhavan K, Johnson DH, Agrawal D. Am J Med; 2018 Jun 07; 131(6):630-632. PubMed ID: 29454719 [No Abstract] [Full Text] [Related]
8. Pharmaceuticals and medical devices: FDA oversight. Chaps NA. Issue Brief Health Policy Track Serv; 2009 Jan 05; ():1-28. PubMed ID: 19297718 [No Abstract] [Full Text] [Related]
9. Running short. Mettner J. Minn Med; 2011 Oct 05; 94(10):8-10. PubMed ID: 23256277 [No Abstract] [Full Text] [Related]
10. Pharmaceuticals and medical devices: business practices. Thomson Reuters Accelus, Steiner DJ. Issue Brief Health Policy Track Serv; 2014 Dec 29; ():1-38. PubMed ID: 25771555 [No Abstract] [Full Text] [Related]
11. Despite Federal Legislation, Shortages Of Drugs Used In Acute Care Settings Remain Persistent And Prolonged. Chen SI, Fox ER, Hall MK, Ross JS, Bucholz EM, Krumholz HM, Venkatesh AK. Health Aff (Millwood); 2016 May 01; 35(5):798-804. PubMed ID: 27140985 [Abstract] [Full Text] [Related]
12. Senator proposes drug shortages law. Thompson CA. Am J Health Syst Pharm; 2011 Mar 15; 68(6):461. PubMed ID: 21378289 [No Abstract] [Full Text] [Related]
13. The Vernacular of Risk--Rethinking Direct-to-Consumer Advertising of Pharmaceuticals. Greene JA, Watkins ES. N Engl J Med; 2015 Sep 17; 373(12):1087-9. PubMed ID: 26287749 [No Abstract] [Full Text] [Related]
14. The Food and Drug Administration and the Pharmaceutical industry. KLUMPP TG. J Indiana State Med Assoc; 1961 Nov 17; 54():1680-90. PubMed ID: 14457165 [No Abstract] [Full Text] [Related]
15. Drug shortages undergo more scrutiny by Congress. Thompson CA. Am J Health Syst Pharm; 2012 Mar 15; 69(6):446, 448, 450. PubMed ID: 22382473 [No Abstract] [Full Text] [Related]
16. The Food and Drug Administration; our mutual responsibility. HOLLAND AH. N Y State J Med; 1955 Aug 15; 55(16):2327-30. PubMed ID: 13244856 [No Abstract] [Full Text] [Related]
17. Disappearing drugs. Conde C. Tex Med; 2012 May 01; 108(5):29-33. PubMed ID: 22714944 [No Abstract] [Full Text] [Related]
18. House legislation proposes early warning system for drug shortages. Thompson CA. Am J Health Syst Pharm; 2011 Aug 01; 68(15):1379-81. PubMed ID: 21785017 [No Abstract] [Full Text] [Related]